Abstract:Fibrocytes were identified as myeloid cells that have fibroblast‐like phenotypes, such as ECM production and differentiation to myofibroblasts. In this review, we introduce the multiple functions of fibrocytes in tumor progression and novel therapeutic strategies targeting fibrocytes. Fibrocytes were identified as bone marrow‐derived myeloid cells that also have fibroblast‐like phenotypes, such as ECM production and differentiation to myofibroblasts. Although fibrocytes are known to contribute to various types of tissue fibrosis, their functions in the tumor microenvironment are unclear. We focused on fibrocytes as pivotal regulators of tumor progression. Our previous studies have indicated that fibrocytes induce angiogenesis and cancer stem cell‐like phenotypes by secreting various growth factors. In contrast, immune checkpoint inhibitor (ICI)‐treated fibrocytes demonstrated antigen‐presenting capacity and enhanced antitumor T cell proliferation. Taken together, these findings indicate that fibrocytes have multiple effects on tumor progression. However, the detailed phenotypes of fibrocytes have not been fully elucidated because the isolation of distinct fibrocyte clusters has not been achieved without culturing in ECM‐coated conditions or intracellular staining of ECM. The development of single‐cell analyses partially resolves these problems. Single‐cell RNA sequences in CD45+ immune cells from tumor tissue identified ECM‐expressing myeloid‐like cells as distinct fibrocyte clusters. In addition, these findings enabled the isolation of tumor‐infiltrating fibrocytes as CD45+CD34+ cells. These tumor‐infiltrating fibrocytes demonstrated both antigen‐presenting ability and differentiation into myofibroblast‐like cancer‐associated fibroblasts. Considering these functions of fibrocytes in tumor progression, molecular‐targeting agents for the migration, activity, and differentiation of fibrocytes are promising therapeutic strategies. Furthermore, identification of specific cell surface markers and master regulators of fibrocytes will advance novel fibrocyte‐targeting therapies. In this review, we discuss the multiple roles of tumor‐infiltrating fibrocytes and novel cancer therapeutic strategies.

Fibrocytes: Emerging Effector Cells in Chronic Inflammation

Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation.

Novel fibroblast phenotypes in homeostasis and chronic inflammation: From functions to potential regulators

Fibroblasts in immune-mediated inflammatory diseases: The soil of inflammation

Innate Lymphoid Cells: A Promising New Regulator In Fibrotic Diseases

Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development

The inflammatory speech of fibroblasts

Fibroblasts in fibrosis: novel roles and mediators

Fibroblasts: Origins, definitions, and functions in health and disease

Fibroblasts at the curtain call: from ensemble to principal dancers in immunometabolism and inflammaging

Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics

Regulation of Fibrosis by the Immune System

Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives

Fibroblast pathology in inflammatory joint disease

Universal and tissue-specific fibroblasts in chronic inflammation and cancer

Fibrocytes: a Potential Therapeutic Cell Population in Chronic Wounds.

From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

Cardiac Fibroblastic Niches in Homeostasis and Inflammation

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities

Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy

New Insight into the Role of Fibroblasts in the Epithelial Immune Microenvironment in the Single-Cell Era